Press "Enter" to skip to content

SoftBank-backed Vir Biotechnology’s shares tumble in market debut

Shares of SoftBank-backed Vir Biotechnology Inc plunged nearly 19.3% on their debut on Friday, adding to the gloom in the IPO market following WeWork’s failed attempt to list on the stock market.

Source:: Technology News

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *